Search

Search results

5006 results found

Mental Health Resources

Page

Substance use treatment: If you are looking for substance use treatment for yourself or your loved one, speak to your doctor or nurse at Bowdoin St. There are resources at the health center to help you. Additional resources are below: Se estiver à procura de tratamento para o consumo de substâncias...

Colon Cancer screening information

Page

Services

Page

Genomics Services The Genomics Core offers Affymetrix gene chip technologies, both cartridges based and 96 well high throughput. We have protocols to analyze genomic information with as little as 50ng of RNA, RNA extracted from paraffin-based samples, or even partially degraded RNA. GeneChip HT...

Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?

Publication: Journal Article

Carlozzi, N E, S Schilling, A L Kratz, J S Paulsen, S Frank, and J C Stout. 2018. “Understanding Patient-Reported Outcome Measures in Huntington Disease: At What Point Is Cognitive Impairment Related to Poor Measurement Reliability?”. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 27 (10): 2541-55.

Differential Gait Decline in Parkinson's Disease Enhances Discrimination of Gait Freezers from Non-Freezers.

Publication: Journal Article

Glover, Aliyah, Lakshmi Pillai, Shannon Doerhoff, and Tuhin Virmani. 2020. “Differential Gait Decline in Parkinson’s Disease Enhances Discrimination of Gait Freezers from Non-Freezers.”. Journal of Parkinson’s Disease 10 (4): 1657-73.

Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.

Publication: Journal Article

Oliveira-Maia, Albino J, Daniel Press, and Alvaro Pascual-Leone. 2017. “Modulation of Motor Cortex Excitability Predicts Antidepressant Response to Prefrontal Cortex Repetitive Transcranial Magnetic Stimulation.”. Brain Stimulation 10 (4): 787-94.

Retromer stabilization using a pharmacological chaperone protects in an α-synuclein based mouse model of Parkinson's.

Publication: Journal Article

Eleuteri, Simona, Tracy Shi Zhang Fang, Gianni Cutillo, Michele Persico, and David K Simon. 2023. “Retromer Stabilization Using a Pharmacological Chaperone Protects in an α-Synuclein Based Mouse Model of Parkinson’s.”. Research Square.

Trial of prasinezumab in early-stage Parkinson’s disease

Publication: Journal Article

Pagano, Gennaro, Kirsten I Taylor, Judith Anzures-Cabrera, Maddalena Marchesi, Tanya Simuni, Kenneth Marek, Ronald B Postuma, et al. 2022. “Trial of Prasinezumab in Early-Stage Parkinson’s Disease”. New England Journal of Medicine 387 (5): 421-32.

Ultra-focal Magnetic Stimulation Using a µTMS coil: a Computational Study

Publication: Journal Article

Colella, Micol, Rebecca M. Laher, Daniel Z. Press, Courtney E. McIlduff, Seward B. Rutkove, Alvaro Pascual-Leone, Francesca Apollonio, Micaela Liberti, and Giorgio Bonmassar. 2019. “Ultra-Focal Magnetic Stimulation Using a µTMS Coil: A Computational Study”. 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 3987-90.

Trial of Cinpanemab in Early Parkinson’s Disease

Publication: Journal Article

Lang, Anthony E., Andrew D. Siderowf, Eric A. Macklin, Werner Poewe, David J. Brooks, Hubert H. Fernandez, Olivier Rascol, et al. 2022. “Trial of Cinpanemab in Early Parkinson’s Disease”. New England Journal of Medicine 387 (5): 408-20.